Filing Details
- Accession Number:
- 0000849146-17-000120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-14 13:24:22
- Reporting Period:
- 2017-11-13
- Accepted Time:
- 2017-11-14 13:24:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 849146 | Lifevantage Corp | LFVN | Pharmaceutical Preparations (2834) | 841097796 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642848 | Jay Darren Jensen | 9785 South Monroe Street, Suite 300 Sandy UT 84070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-13 | 2,000 | $5.06 | 151,358 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.999 to $5.07, inclusive. The reporting person undertakes to provide to LifeVantage Corporation, any security holder of LifeVantage Corporation, or the staff of the Securities and Exchanges Commission, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
